Personalized Health Technologies and Translational Research Conference 2018

A conference on personalized health tools & technologies, addressing the community providing services to biomedical and translational researchers and the translational research for health care in and around Switzerland

When? June 18 to 21, 2018

Where? ETH Zurich, Switzerland

Registration

The registration is open. You can submit your abstracts for contributed talks, flash talks, and posters (max 500 words). You can also profit from reduced prices for accommodation, being a student or retired, and much more.

Registration deadline: May 31
Poster abstract deadline: May 30
Contributed talk abstract deadline: April 27
Subsidized accommodation deadline: May 17

Overview

The next steps in personalized health. This conference brings together experts from multiple disciplines to explore present and future directions in the field of personalized health technologies and translational research. The goal is to tackle challenges in chemical hit identification, lead development, molecular circuit analyses, clinical bioinformatics, and multivariate statistics, as well as their application in innovative clinical personalized health approaches in oncology, immunology, infectious diseases, neurology, and cardiology.

From patient samples to molecular read outs. Progress in the laboratory representation of clinical material has enabled novel possibilities for discovery and diagnostics with thus far unrivaled proximity to the patient. Advanced cell systems such as organoids allow for in-depth molecular profiling and functional studies as well as investigation of responses to chemical and therapeutic agents. Combined with high-throughput screening and chemical biology, empirical projects of very large scope have not only become conceivable but also present themselves with feasible turnaround time.

Integration of molecular modalities and global knowledge. The continuous development of next-generation sequencing and mass spectrometry measurements allow for high-resolution characterization of biomolecules derived from patient samples or mouse models of disease. While early challenges of storage and compute capacity have largely been addressed, present ones are the integration and combined analysis of multifaceted data, including public online resources.

The future of translation — together. Research and development for personalized health show the greatest promise when all stakeholders collaborate closely. This includes the academic and clinical institutions, core facilities and medical labs, as well as hospitals and ultimately the patients.

Speakers for Tools & Technologies

Calvin Kuo
Stanford University
Olivier Elemento
Weill Cornell Medicine
Lillian L. Siu
Princess Margaret Cancer Centre
Tewis Bouwmeester
Novartis
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center

Speakers for Translational Research

Diederick E. Grobbee
UMC Utrecht
Rebecca Kristeleit
University College London Hospital
Guisi Moffa
University Hospital Basel
Carl H. June
University of Pennsylvania
Nicholas J. Schork
J. Craig Venter Institute
Antonio Lanzavecchia
Università della Svizzera italiana

Mikael Pittet
Massachusetts General Hospital
Sergio Quezeda
University College London Cancer Institute
Alessandra Curioni
University Hospital Zurich
Adrian Ochsenbein
University Hospital Bern
Michael Huber
University of Zurich
Jacques Schrenzel
University of Geneva Hospitals
Zlatko Trajanoski
Medical University of Innsbruck
Roger Kouyos
University Hospital Zurich
Andreas Lutterotti
University Hospital Zurich
Rebecca Burkholz
ETH Zurich
Ivo Strebel
University Hospital Basel
Isabelle Mansuy
University Hospital and ETH Zurich

Main Sponsors

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche Diagnostics is the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

The biotechnet Switzerland helps you access a wide variety of competencies in biotechnology of Swiss Universities of Applied Sciences, Universities and Research and Technology Organizations. Many industrial partners have relied on our proven support and services in research and development. We can help you too. Have a look at what we offer.

Sponsors

Agenda

The conference will be structured in nine sessions. The first four sessions (June 18-19) are organized by NEXUS Personalized Health Technologies with a focus on tools & technologies and the last 5 sessions (June 20-21) by the Personalized Health Alliance Zurich-Basel (PH Alliance) with a focus on translation & research:



Monday 18 June 2018
08:30 - 09:00
Arrival & Registration
09:00 - 09:15
Welcome Address
Session 1 - Advanced Cell Systems (G. Schwank)
09:15 - 10:15
Calvin Kuo (Stanford)
10:15 - 10:45
Contributed Talk
Coffee Break

11:15 - 11:45
Contributed Talk
11:45 - 12:15
Contributed Talk
Lunch & Poster Session
Session 2 - Variant Interpretation (N. Beerenwinkel)
13:45 - 14:45
Olivier Elemento (Weill Cornell)
14:45 - 15:15
Contributed Talk
Coffee Break

15:45 - 16:15
Contributed Talk
16:15 - 16:45
Contributed Talk
16:45 - 18:30
Apéro & Poster Session
Tuesday 19 June 2018
08:30 - 09:15
Arrival & Registration

Session 3 - Novel Therapeutics (K.H. Altmann)
09:15 - 10:15
Tewis Bouwmeester (Novartis)
10:15 - 10:45
Contributed Talk
Coffee Break

11:15 - 12:15
Lillian Siu (Toronto)
Lunch & Poster Session
Session 4 - Integration of Clinical Data (G. Rätsch)
13:45 - 14:45
Nikolaus Schultz (MSKCC)
14:45 - 15:15
Contributed Talk
Coffee Break

15:45 - 16:15
Contributed Talk
16:15 - 16:45
Contributed Talk
18:00
Conference Dinner



Wednesday 20 June 2018
08:00 - 08:45
Arrival & Registration
08:45 - 09:00
Welcome Address
Session 5 - Infectiology (H. Günthard, USZ)
09:00 - 09:20
A. Lanzavecchia (USI)
09:20 - 09:40
M. Huber (UZH)
09:40 - 10:00
J. Schrenzel (HUG)
10:00 - 10:20
R. Kouyos (UZH)
10:20 - 11:00
Panel Discussion
11:00 - 11:30
Flash Talks
Lunch & Poster Session
Session 6 – Immunology (A. Zippelius, USB)
13:00 - 13:20
C. June (UPenn)
13:20 - 13:40
Z. Trajanoski (MU Innsbruck)
13:40 - 14:00
S. Quezeda (UCL)
14:00 - 14:20
M. Pittet (MGH)
14:20 - 15:00
Panel Discussion
Coffee Break

Session 7 – Oncology (A. Wicki, USB)
15:30 - 15:50
R. Kristeleit (UCL)
15:50 - 16:10
G. Moffa (Unibas)
16:10 - 16:30
A. Ochsenbein (Unibe)
16:30 - 16:50
A. Curioni (USZ)
16:50 - 17:30
Panel Discussion
17:30 - 19:00
Apéro & Poster Session
Thursday 21 June 2018
08:30 - 09:00
Arrival & Registration
Session 8 – Neurology (R. Martin, USZ)
09:00 - 09:20
N. Schork (Craig Venter Institute)
09:20 - 09:40
A. Lutterotti (USZ)
09:40 - 10:00
I. Mansuy (USZ/ETH Zurich)
10:00 - 10:20
N.N.
10:20 - 11:00
Panel Discussion
11:00 - 11:30
Flash Talks
Lunch & Poster Session
Session 9 – Cardiology (F. Ruschitzka, USZ)
13:00 - 13:20
D. Grobbee (UMC Utrecht)
13:20 - 13:40
R. Burkholz (ETH Zurich)
13:40 - 14:00
I. Strebel (USB)
14:00 - 14:20
N. N.
14:20 - 15:00
Panel Discussion
15:05 - 16:00
Summary & Farewell Coffee

Organizers

NEXUS Personalized Health Technologies

NEXUS is an ETH Technology Platform created to enable and accelerate the execution of translational research projects by providing key technological resources, tools and collaboration opportunities for the personalized health research community.

Niko Beerenwinkel
D-BSSE, ETH Zurich
SIB
Markus Stoffel
D-BIOL, ETH Zurich
Daniel Stekhoven
NEXUS, ETH Zurich
SIB
Christian Stirnimann
NEXUS, ETH Zurich



Personalized Health Alliance Zurich-Basel

The purpose of the PH Alliance is to combine the complementary local strengths into a regional research cluster of scientific excellence in order to form strong research networks between University of Zurich, ETH Zurich, University Hospitals Zurich, University of Basel, and University Hospitals Basel. In a bottom-up approach the Alliance is strengthening the exchange of ideas and collaboration across clinical, scientific, and bioinformatical research groups from both regions.

Margrit Leuthold
ETH Zurich
PH Alliance Zurich
Silke Schneider
ETH Zurich
University of Zurich
PH Alliance Zurich
Thomas Geiger
University of Basel
PH Alliance Basel
Niko Beerenwinkel
D-BSSE, ETH Zurich
SIB

Contact

Please contact us for further information at personalizedhealth@nexus.ethz.ch

Disclaimer

Although the organizers take all possible care to ensure the correctness of published information, no warranty can be accepted regarding the correctness, accuracy, reliability and completeness of the content of this information.

The organizers expressly reserve the right to change, to delete or temporarily not to publish the contents wholly or partly at any time and without giving notice.

Liability claims against the organizers or their affiliated institutions, namely ETH Zurich, University of Zurich, University Hospital Zurich, University Basel, because of tangible or intangible damage arising from accessing, using or not using the published information, through misuse of the connection or as a result of technical breakdowns are excluded.

The organizers have not checked third party web sites, i.e. web sites not located on their servers or in their area of influence, that may be connected to this web site via links, and do not accept any responsibility for the contents or the services offered thereon.

Venue

ETH Zurich main building
HG F 30 (Audi Max)
Rämistrasse 101
CH-8092 Zurich
Switzerland